Zinc in PDB 3f07: Crystal Structure Analysis of Human HDAC8 Complexed with Apha in A New Monoclinic Crystal Form
Enzymatic activity of Crystal Structure Analysis of Human HDAC8 Complexed with Apha in A New Monoclinic Crystal Form
All present enzymatic activity of Crystal Structure Analysis of Human HDAC8 Complexed with Apha in A New Monoclinic Crystal Form:
3.5.1.98;
Protein crystallography data
The structure of Crystal Structure Analysis of Human HDAC8 Complexed with Apha in A New Monoclinic Crystal Form, PDB code: 3f07
was solved by
D.P.Dowling,
S.L.Gantt,
S.G.Gattis,
C.A.Fierke,
D.W.Christianson,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
31.50 /
3.30
|
Space group
|
P 1 21 1
|
Cell size a, b, c (Å), α, β, γ (°)
|
88.381,
90.171,
92.267,
90.00,
94.74,
90.00
|
R / Rfree (%)
|
21.6 /
26
|
Other elements in 3f07:
The structure of Crystal Structure Analysis of Human HDAC8 Complexed with Apha in A New Monoclinic Crystal Form also contains other interesting chemical elements:
Zinc Binding Sites:
The binding sites of Zinc atom in the Crystal Structure Analysis of Human HDAC8 Complexed with Apha in A New Monoclinic Crystal Form
(pdb code 3f07). This binding sites where shown within
5.0 Angstroms radius around Zinc atom.
In total 4 binding sites of Zinc where determined in the
Crystal Structure Analysis of Human HDAC8 Complexed with Apha in A New Monoclinic Crystal Form, PDB code: 3f07:
Jump to Zinc binding site number:
1;
2;
3;
4;
Zinc binding site 1 out
of 4 in 3f07
Go back to
Zinc Binding Sites List in 3f07
Zinc binding site 1 out
of 4 in the Crystal Structure Analysis of Human HDAC8 Complexed with Apha in A New Monoclinic Crystal Form
Mono view
Stereo pair view
|
A full contact list of Zinc with other atoms in the Zn binding
site number 1 of Crystal Structure Analysis of Human HDAC8 Complexed with Apha in A New Monoclinic Crystal Form within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Zn400
b:37.9
occ:1.00
|
OD2
|
A:ASP178
|
2.0
|
39.6
|
1.0
|
ND1
|
A:HIS180
|
2.1
|
46.8
|
1.0
|
OD2
|
A:ASP267
|
2.1
|
35.7
|
1.0
|
O2
|
A:AGE500
|
2.4
|
63.0
|
0.7
|
O1
|
A:AGE500
|
2.6
|
59.5
|
0.7
|
C16
|
A:AGE500
|
2.6
|
62.8
|
0.7
|
N2
|
A:AGE500
|
2.7
|
61.5
|
0.7
|
CE1
|
A:HIS180
|
2.8
|
48.3
|
1.0
|
CG
|
A:ASP178
|
2.9
|
38.0
|
1.0
|
CG
|
A:ASP267
|
3.0
|
37.5
|
1.0
|
OD1
|
A:ASP178
|
3.1
|
37.7
|
1.0
|
CG
|
A:HIS180
|
3.2
|
45.6
|
1.0
|
OD1
|
A:ASP267
|
3.4
|
37.9
|
1.0
|
CB
|
A:HIS180
|
3.7
|
44.2
|
1.0
|
C15
|
A:AGE500
|
3.8
|
64.2
|
0.7
|
N
|
A:HIS180
|
3.9
|
41.4
|
1.0
|
CA
|
A:GLY304
|
3.9
|
50.8
|
1.0
|
NE2
|
A:HIS180
|
4.0
|
47.8
|
1.0
|
CB
|
A:ASP267
|
4.2
|
38.7
|
1.0
|
CD2
|
A:HIS180
|
4.2
|
46.5
|
1.0
|
CB
|
A:ASP178
|
4.3
|
37.1
|
1.0
|
NE2
|
A:HIS142
|
4.3
|
50.7
|
1.0
|
N
|
A:LEU179
|
4.3
|
37.9
|
1.0
|
N
|
A:GLY304
|
4.4
|
50.3
|
1.0
|
CA
|
A:HIS180
|
4.5
|
42.9
|
1.0
|
C14
|
A:AGE500
|
4.5
|
65.7
|
0.7
|
CB
|
A:LEU179
|
4.6
|
37.6
|
1.0
|
OH
|
A:TYR306
|
4.6
|
61.6
|
1.0
|
CE1
|
A:TYR306
|
4.7
|
60.2
|
1.0
|
CE1
|
A:HIS142
|
4.7
|
50.9
|
1.0
|
NE2
|
A:HIS143
|
4.8
|
50.0
|
1.0
|
CA
|
A:LEU179
|
4.8
|
38.7
|
1.0
|
C
|
A:LEU179
|
4.8
|
40.1
|
1.0
|
|
Zinc binding site 2 out
of 4 in 3f07
Go back to
Zinc Binding Sites List in 3f07
Zinc binding site 2 out
of 4 in the Crystal Structure Analysis of Human HDAC8 Complexed with Apha in A New Monoclinic Crystal Form
Mono view
Stereo pair view
|
A full contact list of Zinc with other atoms in the Zn binding
site number 2 of Crystal Structure Analysis of Human HDAC8 Complexed with Apha in A New Monoclinic Crystal Form within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Zn409
b:68.2
occ:0.70
|
ND1
|
A:HIS90
|
2.0
|
86.6
|
1.0
|
NE2
|
A:HIS78
|
2.2
|
76.5
|
1.0
|
OD1
|
A:ASP92
|
2.6
|
72.8
|
1.0
|
OD2
|
A:ASP87
|
2.7
|
91.7
|
1.0
|
CG
|
A:HIS90
|
2.7
|
87.8
|
1.0
|
CE1
|
A:HIS78
|
2.7
|
77.1
|
1.0
|
CB
|
A:HIS90
|
2.8
|
88.7
|
1.0
|
CE1
|
A:HIS90
|
3.2
|
86.1
|
1.0
|
CG
|
A:ASP92
|
3.5
|
73.3
|
1.0
|
CD2
|
A:HIS78
|
3.5
|
76.4
|
1.0
|
CG
|
A:ASP87
|
3.6
|
93.2
|
1.0
|
N
|
A:SER93
|
3.7
|
66.9
|
1.0
|
CA
|
A:SER93
|
3.7
|
64.1
|
1.0
|
OD2
|
A:ASP92
|
3.8
|
73.4
|
1.0
|
CG1
|
A:VAL82
|
3.8
|
78.2
|
1.0
|
OD1
|
A:ASP87
|
3.9
|
92.4
|
1.0
|
CD2
|
A:HIS90
|
4.0
|
87.7
|
1.0
|
ND1
|
A:HIS78
|
4.0
|
77.0
|
1.0
|
CB
|
A:SER93
|
4.0
|
64.6
|
1.0
|
CA
|
A:HIS90
|
4.1
|
89.2
|
1.0
|
O
|
A:HIS90
|
4.1
|
87.9
|
1.0
|
NE2
|
A:HIS90
|
4.2
|
86.2
|
1.0
|
C
|
A:ASP92
|
4.3
|
69.9
|
1.0
|
C
|
A:HIS90
|
4.4
|
87.3
|
1.0
|
CG
|
A:HIS78
|
4.4
|
76.1
|
1.0
|
CB
|
A:ASP92
|
4.7
|
73.1
|
1.0
|
O
|
A:ASP92
|
4.8
|
69.0
|
1.0
|
CB
|
A:ASP87
|
4.9
|
94.6
|
1.0
|
N
|
A:ASP92
|
4.9
|
76.8
|
1.0
|
CA
|
A:ASP92
|
4.9
|
72.9
|
1.0
|
|
Zinc binding site 3 out
of 4 in 3f07
Go back to
Zinc Binding Sites List in 3f07
Zinc binding site 3 out
of 4 in the Crystal Structure Analysis of Human HDAC8 Complexed with Apha in A New Monoclinic Crystal Form
Mono view
Stereo pair view
|
A full contact list of Zinc with other atoms in the Zn binding
site number 3 of Crystal Structure Analysis of Human HDAC8 Complexed with Apha in A New Monoclinic Crystal Form within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Zn403
b:40.4
occ:1.00
|
ND1
|
B:HIS180
|
2.0
|
47.4
|
1.0
|
OD2
|
B:ASP267
|
2.0
|
35.4
|
1.0
|
OD2
|
B:ASP178
|
2.1
|
34.8
|
1.0
|
C16
|
B:AGE501
|
2.3
|
68.2
|
0.7
|
N2
|
B:AGE501
|
2.4
|
67.7
|
0.7
|
O2
|
B:AGE501
|
2.4
|
68.1
|
0.7
|
O1
|
B:AGE501
|
2.5
|
68.3
|
0.7
|
CE1
|
B:HIS180
|
2.7
|
47.7
|
1.0
|
CG
|
B:ASP178
|
2.9
|
35.6
|
1.0
|
CG
|
B:ASP267
|
3.0
|
38.0
|
1.0
|
OD1
|
B:ASP178
|
3.1
|
35.3
|
1.0
|
CG
|
B:HIS180
|
3.2
|
46.8
|
1.0
|
C15
|
B:AGE501
|
3.3
|
69.5
|
0.7
|
OD1
|
B:ASP267
|
3.4
|
38.4
|
1.0
|
CB
|
B:HIS180
|
3.7
|
45.0
|
1.0
|
N
|
B:HIS180
|
3.8
|
41.4
|
1.0
|
NE2
|
B:HIS180
|
3.9
|
46.2
|
1.0
|
CA
|
B:GLY304
|
4.0
|
49.5
|
1.0
|
C14
|
B:AGE501
|
4.0
|
71.4
|
0.7
|
CD2
|
B:HIS180
|
4.2
|
46.8
|
1.0
|
CB
|
B:ASP267
|
4.2
|
38.9
|
1.0
|
N
|
B:LEU179
|
4.3
|
39.4
|
1.0
|
CB
|
B:ASP178
|
4.3
|
36.7
|
1.0
|
NE2
|
B:HIS142
|
4.4
|
50.6
|
1.0
|
N
|
B:GLY304
|
4.4
|
49.6
|
1.0
|
CA
|
B:HIS180
|
4.4
|
43.1
|
1.0
|
CB
|
B:LEU179
|
4.5
|
38.4
|
1.0
|
OH
|
B:TYR306
|
4.6
|
63.4
|
1.0
|
CE1
|
B:TYR306
|
4.7
|
61.5
|
1.0
|
CE1
|
B:HIS142
|
4.7
|
51.1
|
1.0
|
CA
|
B:LEU179
|
4.8
|
39.4
|
1.0
|
C
|
B:LEU179
|
4.8
|
40.3
|
1.0
|
NE2
|
B:HIS143
|
4.8
|
52.6
|
1.0
|
|
Zinc binding site 4 out
of 4 in 3f07
Go back to
Zinc Binding Sites List in 3f07
Zinc binding site 4 out
of 4 in the Crystal Structure Analysis of Human HDAC8 Complexed with Apha in A New Monoclinic Crystal Form
Mono view
Stereo pair view
|
A full contact list of Zinc with other atoms in the Zn binding
site number 4 of Crystal Structure Analysis of Human HDAC8 Complexed with Apha in A New Monoclinic Crystal Form within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
C:Zn406
b:48.2
occ:1.00
|
ND1
|
C:HIS180
|
2.0
|
48.4
|
1.0
|
OD2
|
C:ASP267
|
2.0
|
43.5
|
1.0
|
OD2
|
C:ASP178
|
2.0
|
37.9
|
1.0
|
O
|
C:HOH813
|
2.2
|
29.5
|
1.0
|
CE1
|
C:HIS180
|
2.7
|
49.3
|
1.0
|
CG
|
C:ASP178
|
2.9
|
39.7
|
1.0
|
CG
|
C:ASP267
|
3.0
|
44.0
|
1.0
|
OD1
|
C:ASP178
|
3.1
|
39.6
|
1.0
|
CG
|
C:HIS180
|
3.1
|
48.0
|
1.0
|
OD1
|
C:ASP267
|
3.4
|
45.6
|
1.0
|
CB
|
C:HIS180
|
3.7
|
46.6
|
1.0
|
N
|
C:HIS180
|
3.8
|
44.2
|
1.0
|
NE2
|
C:HIS180
|
3.9
|
48.6
|
1.0
|
CA
|
C:GLY304
|
4.0
|
53.6
|
1.0
|
CD2
|
C:HIS180
|
4.1
|
47.9
|
1.0
|
CB
|
C:ASP267
|
4.2
|
41.9
|
1.0
|
N
|
C:LEU179
|
4.2
|
41.5
|
1.0
|
CB
|
C:ASP178
|
4.3
|
39.9
|
1.0
|
NE2
|
C:HIS142
|
4.3
|
55.7
|
1.0
|
CA
|
C:HIS180
|
4.4
|
45.5
|
1.0
|
CB
|
C:LEU179
|
4.5
|
39.8
|
1.0
|
N
|
C:GLY304
|
4.5
|
53.6
|
1.0
|
OH
|
C:TYR306
|
4.6
|
64.2
|
1.0
|
CE1
|
C:HIS142
|
4.7
|
55.9
|
1.0
|
CE1
|
C:TYR306
|
4.7
|
62.7
|
1.0
|
CA
|
C:LEU179
|
4.7
|
42.3
|
1.0
|
C
|
C:LEU179
|
4.8
|
43.5
|
1.0
|
NE2
|
C:HIS143
|
4.8
|
61.9
|
1.0
|
|
Reference:
D.P.Dowling,
S.L.Gantt,
S.G.Gattis,
C.A.Fierke,
D.W.Christianson.
Structural Studies of Human Histone Deacetylase 8 and Its Site-Specific Variants Complexed with Substrate and Inhibitors. Biochemistry V. 47 13554 2008.
ISSN: ISSN 0006-2960
PubMed: 19053282
DOI: 10.1021/BI801610C
Page generated: Thu Oct 24 12:59:44 2024
|